Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CASP3 | P42574 | 20/20 | 0.57 |
| ▸ | CASP6 | P55212 | 20/20 | 0.57 |
| ▸ | CASP8 | Q14790 | 20/20 | 0.57 |
| ▸ | CASP7 | P55210 | 1/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4555542 | 0.92 | CASP3 (0.59) | CASP3CASP6CASP8CASP7 | |
| SCHEMBL1894505 | 0.92 | CASP3 (0.59) | CASP3CASP6CASP8CASP7 | |
| SCHEMBL4556928 | 0.91 | CASP3 (0.58) | CASP3CASP6CASP8CASP7 | |
| SCHEMBL4557103 | 0.90 | CASP3 (0.61) | CASP3CASP6CASP8CASP7 | |
| SCHEMBL4557046 | 0.90 | CASP3 (0.60) | CASP3CASP6CASP8CASP7 | |
| SCHEMBL4555795 | 0.89 | CASP3 (0.61) | CASP3CASP6CASP8CASP7 | |
| SCHEMBL1895586 | 0.89 | CASP3 (0.61) | CASP3CASP6CASP8CASP7 | |
| SCHEMBL1899349 | 0.89 | CASP3 (0.61) | CASP3CASP6CASP8CASP7 | |
| SCHEMBL4556819 | 0.89 | CASP3 (0.61) | CASP3CASP6CASP8CASP7 | |
| SCHEMBL4556692 | 0.89 | CASP3 (0.61) | CASP3CASP6CASP8CASP7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1091930-B1 | C-TERMINAL MODIFIED OXAMYL DIPEPTIDES AS INHIBITORS OF THE ICE/ced-3 FAMILY OF CYSTEINE PROTEASES | IDUN PHARMACEUTICALS INC (US) | 2006-12-13 | — | — | EP | claimed |
| EP-2086641-A2 | EGFR KINASE INHIBITOR COMBINATIONS FOR THE TREATMENT OF RESPIRATORY AND GASTROINTESTINAL DISORDERS | Boehringer Ingelheim International GmbH (DE) | 2009-08-12 | — | — | EP | disclosed |
| WO-2008049842-A2 | EGFR KINASE INHIBITOR COMBINATIONS FOR THE TREATMENT OF RESPIRATORY AND GASTROINTESTINAL DISORDERS | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2008-05-02 | — | — | WO | disclosed |